Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer
Open Access
- 18 December 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Urology
- Vol. 12 (1), 37
- https://doi.org/10.1186/1471-2490-12-37
Abstract
Bladder cancer is a significant cause of morbidity and mortality with a high recurrence rate. Early detection of bladder cancer is essential in order to remove the tumor, to preserve the organ and to avoid metastasis. The aim of this study was to analyze the differential expression of mitochondrial non-coding RNAs (sense and antisense) in cells isolated from voided urine of patients with bladder cancer as a noninvasive diagnostic assay. The differential expression of the sense (SncmtRNA) and the antisense (ASncmtRNAs) transcripts in cells isolated from voided urine was determined by fluorescent in situ hybridization. The test uses a multiprobe mixture labeled with different fluorophores and takes about 1 hour to complete. We examined the expression of these transcripts in cells isolated from urine of 24 patients with bladder cancer and from 15 healthy donors. This study indicates that the SncmtRNA and the ASncmtRNAs are stable in cells present in urine. The test reveals that the expression pattern of the mitochondrial transcripts can discriminate between normal and tumor cells. The analysis of 24 urine samples from patients with bladder cancer revealed expression of the SncmtRNA and down-regulation of the ASncmtRNAs. Exfoliated cells recovered from the urine of healthy donors do not express these mitochondrial transcripts. This is the first report showing that the differential expression of these mitochondrial transcripts can detect tumor cells in the urine of patients with low and high grade bladder cancer. This pilot study indicates that fluorescent in situ hybridization of cells from urine of patients with different grades of bladder cancer confirmed the tumor origin of these cells. Samples from the 24 patients with bladder cancer contain cells that express the SncmtRNA and down-regulate the ASncmtRNAs. In contrast, the hybridization of the few exfoliated cells recovered from healthy donors revealed no expression of these mitochondrial transcripts. This assay can be explored as a non-invasive diagnostic tool for bladder cancer.Keywords
This publication has 34 references indexed in Scilit:
- Expression of Mitochondrial Non-coding RNAs (ncRNAs) Is Modulated by High Risk Human Papillomavirus (HPV) OncogenesJournal of Biological Chemistry, 2012
- Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysisBMC Cancer, 2011
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 UpdateEuropean Urology, 2011
- Miniaturized FISH for Screening of Onco-Hematological MalignanciesBioTechniques, 2010
- Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle-Invasive Bladder CancerThe Journal of Molecular Diagnostics, 2009
- Translocation t(11;14) and survival of patients with light chain (AL) amyloidosisHaematologica, 2009
- Expression of a novel non-coding mitochondrial RNA in human proliferating cellsNucleic Acids Research, 2007
- Guidance for Fluorescence in Situ Hybridization Testing in Hematologic DisordersThe Journal of Molecular Diagnostics, 2007
- A novel multiple FISH array for the detection of genetic aberrations in cancerLaboratory Investigation, 2006